z-logo
open-access-imgOpen Access
Disease-modifying therapies should be stopped in NMOSD patients in remission – Yes
Author(s) -
Shosha Eslam
Publication year - 2019
Publication title -
multiple sclerosis journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.729
H-Index - 131
eISSN - 1477-0970
pISSN - 1352-4585
DOI - 10.1177/1352458519829694
Subject(s) - multiple sclerosis , medicine , disease , relapsing remitting , complete remission , immunology , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom